Multiple Myeloma Clinical Trials in Eugene, Oregon

6 studies are recruiting for multiple myeloma in Eugene, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

    This is a Phase II, open-label, nonrandomized, single-arm study of elranatamab that will be administered in the outpatient setting in 2 sequential cohorts of participants with relapsed or refractory multiple myeloma (RRMM). The primary objective of this study is to evaluate the overall incidence of…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Willamette Valley Cancer Institute and Research Center, Eugene, Oregon
    Locations
    6 in total
    Run by
    SCRI Development Innovations, LLC

    See if you can join NCT07637578 on ClinicalTrials.gov

  2. A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

    The purpose of this study is to evaluate how well JNJ-79635322 works (efficacy) in participants with Relapsed or Refractory Multiple Myeloma (RRMM; a cancer that forms in a type of white blood cells called a plasma cell. Cancer is called relapsed if it comes back after treatment and is called 'refr…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Oncology Associates of Oregon PC Willamette Valley Cancer Institute, Eugene, Oregon
    Locations
    71 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07266441 on ClinicalTrials.gov

  3. A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

    Multiple Myeloma (MM) is a cancer of the blood's plasma cells ( blood cell). The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can come…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Willamette Valley Cancer Institute and Research Center /ID# 267088, Eugene, Oregon
    Locations
    46 in total
    Run by
    AbbVie

    See if you can join NCT05650632 on ClinicalTrials.gov

  4. A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. This is a study to determine the adverse events, change…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Willamette Valley Cancer Institute and Research Center /ID# 278721, Eugene, Oregon
    Locations
    49 in total
    Run by
    AbbVie

    See if you can join NCT07095452 on ClinicalTrials.gov

  5. Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

    This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Oncology Associates of Oregon, Eugene, Oregon
    Locations
    17 in total
    Run by
    SCRI Development Innovations, LLC

    See if you can join NCT05972135 on ClinicalTrials.gov

  6. A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

    A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in patients with acute leukemia.

    Stage
    Phase 1
    Ages
    12 and older
    Site
    Oncology Associates of Oregon, Eugene, Oregon
    Locations
    104 in total
    Run by
    Sumitomo Pharma America, Inc.

    See if you can join NCT04988555 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.